Here’s your go-to guide with everything you need to know about COVID-19, including the latest "FLiRT"variants and concerns ...

Moderna beat first-quarter expectations Thursday. The news could bolster Moderna stock which is approaching its first ...

All vaccines have at least occasional side effects. But people who say they were injured by COVID vaccines believe their cases have been ignored.

The US Food and Drug Administration (FDA) has approved Labcorp’s nAbCyte Anti-AAVRh74var HB-FE assay as a companion diagnostic to Pfizer’s Beqvez (fidanacogene elaparvovec-dzkt). The assay ...

Pfizer (NYSE:PFE) and Danish drugmaker Genmab (GMAB) announced Monday that the U.S. FDA accepted a supplemental Biologics License Application granting full approval for their cervical cancer ...

Pfizer and Genmab’s Tivdak (tisotumab vedotin-tftv) has won full approval from the US Food and Drug Administration (FDA) to treat patients with recurrent or metastatic cervical cancer with ...

The U.S. Food and Drug Administration (FDA) granted full approval for Pfizer's drug for treating cervical cancer patients whose disease had progressed on or after chemotherapy, the agency said on ...

Sharp-eyed grocery shoppers may notice new labels in the dairy aisle touting yogurt as way to reduce the risk of Type 2 ...

The FDA approved the subcutaneous form as a maintenance ... versus just 11% in the placebo group, at the 12-week mark. Pfizer-BioNTech’s and Moderna’s mRNA-based COVID-19 vaccines have been ...

The first patients have been dosed in a phase 3 trial of an mRNA-based seasonal influenza vaccine developed by Pfizer and BioNTech ... and greater efficacy than shots made using traditional ...

Hong Kong will make BioNTech coronavirus booster shots available to all age-eligible city residents from January, the city’s leader has announced. But Chief Executive Carrie Lam Cheng Yuet-ngor ...